our experience
Many clients have already trusted the OPTIMARC CRAs in various therapeutic areas. To this collective experience, each individual’s experience should be added: therapeutic, medical devices, cellular therapy, etc. (nutraceutical, epidemiology, observational, Temporary Authorization for Use, cosmetics, veterinary projects).
|
PATHOLOGY |
PHASE |
NUMBER OF SITES |
NUMBER OF PATIENTS |
|---|---|---|---|
|
Lung cancer |
II (5 trials) |
110 |
438 |
|
Hepatitis C |
Pharmaco-epidemiological study |
200 |
- |
|
Myocardial infarction |
Epidemiological Inquiry |
176 |
968 |
|
Glaucoma |
Observationnal Inquiry |
71 |
142 |
|
Infectiology |
IIIb |
39 |
- |
|
Epilepsy |
III |
24 |
- |
|
Menopause |
III |
39 |
135 |
|
Depressive syndrome |
IV |
42 |
45 |
|
Influenza |
Pharmaco-epidemiological study (2 trials) |
300 |
- |
|
Pancreas cancer |
III |
17 |
77 |
|
Hypercholesterolaemia |
III |
36 |
- |
|
High Blood Pressure |
IV |
559 |
- |
|
Presbytia |
IV |
6 |
100 |
|
Vertebral fracture |
Medico-economic study |
82 |
- |
|
Antibiotherapy and vaccination for dogs and cats |
III and IV |
6 |
10 |
|
HIV |
IIIb |
6 |
49 |
|
Birth Control |
III |
65 |
223 |
|
Intertrigo |
IV |
25 |
- |
|
Children's diarrhea |
III |
24 |
420 |
|
Pollakiuria |
IIb |
3 |
- |
|
Anemia |
Pharmaco-epidemiological study |
250 |
- |
|
Hypogonadism |
III |
